FDA Inspection 1305832 — Curia New York, Inc.
The FDA completed an inspection of Curia New York, Inc. on Feb 5, 2026 in Rensselaer, NY. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Feb 5, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rensselaer, NY (United States)